Cell Processing Track

Pre-Conference Workshop
Wednesday, May 2
08:30 - 16:15

This track will focus on aspects of cell processing relevant to manufacturing of cell-based products. Experts and Key Opinion Leaders on the topic will share their experiences and views on potency assays and cell characterization by flow cytometry. The cell processing track aims at reproducible, safe and sustainable methods applicable in manufacturing settings for cell-based products intended for cellular therapy.

Program Information

Chair:
Sarah Nikiforow, MD, PhD, Dana Farber Cancer Institute, United States
Speakers:

Locally Produced Dual Targeted anti-CD19/anti-CD20 CAR-T cell Therapy for Patients with Relapsed, Refractory NHL
Nirav Shah, MD, MS, 
Medical College of Wisconsin, United States

Improved Cell Recovery and Response by the use of Deterministic Lateral Displacement in Blood Product Processing
Tony Ward, MBA, 
GPB Scientific, United States

Approaches to iPSC Generation
Vittorio Sebastiano, PhD, Stanford School of Medicine, United States

Chair:
David DiGiusto, PhD, Stanford Healthcare and Stanford School of Medicine, United States

Speakers:

Approaches to Assessing Cell Function
Adrian Gee, PhD Baylor College of Medicine, United States

Industry Perspective on Quality Control and Release Testing
Jean-Pierre Latere, PhD, Celyad, Belgium

VCN and RCL Testing for Lentiviral Vectors
Lindsay Skrdlant, PhD, Stanford University School of Medicine, United States

Chair:
Ruud Hulspaas, PhD , Cellular Technologies Bioconsulting, United States


Speakers:

When Stem Cells Meet Immunotherapy: The Critical Role of Multi-Parameter Flow Cytometry In The Development of Off-The-Shelf Cell Therapies
Tamara Laskowski, PhD, 
MD Anderson Cancer Center, United States

Flow Cytometry Standardization and Robust Cell Antigen Quantification: A Road Toward Predicting Cell Biological Characteristics
Heba Degheidy, MD, PhD
, FDA, United States

Quantitative Flow Cytometry in Cell Therapy
Ines Mende, PhD
, Hitachi Chemical Advanced Therapeutic Solutions, LLC

Chair:
Ruud Hulspaas, PhD, Cellular Technologies Bioconsulting, United States
Speakers:

Mechanisms of Response and Resistance to CD19-targeting Chimeric Antigen Receptors in Leukemia
J. Joseph Melenhorst, PhD
,  University of Pennsylvania, United States

Case Studies in Multi-Parameter Flow Cytometric Characterization of TCR, TIL, and CAR-T Cell Therapy Products
Sadik Kassim, PhD, Mustang Bio, United States

Multi-parameter Flow Cytometry in Product Characterization of Therapeutic Cells
Kathryn Holderness, MS, Lonza, United States

To view the full meeting program, please refer to the program schedule.

Confirmed Speakers

David DiGiusto, PhD, Stanford Healthcare and Stanford School of Medicine, United States

Heba Degheidy, MD, PhD, FDA, United States

Adrian Gee, PhD Baylor College of Medicine, United States

Kathryn Holderness, MS, Lonza, United States

Ruud Hulspas, PhD, Cellular Technologies Bioconsulting, United States

Sadik Kassim, PhD, Mustang Bio, United States

Tamara Laskowksi, PhD, MD Anderson Cancer Center, United States

Jean-Pierre Latere, PhD, Celyad, Belgium

J. Joseph Melenhorst, PhD, University of Pennsylvania, United States

Sarah Nikiforow, MD, PhD, Dana Farber Cancer Institute, United State

Vittorio Sebastiano, PhD, Stanford School of Medicine, United States

Nirav Shah, MD, MS, Medical College of Wisconsin, United States

Lindsay Skrdlant, PhD, Stanford University School of Medicine, United States

Tony Ward, MBA, GPB Scientific, United States